Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

CLOZAPINE N-OXIDE

CLOZAPINE N-OXIDE
Clozapine N-oxide is the major metabolite of Clozapine and is blood-brain barrier permeable. Clozapine N-oxide is an agonist of DREADDs and activates the DREADD receptors hM3Dq and hM4Di. Clozapine N-oxide is also a dopamine antagonist and selective muscarinic M4 receptor agonist.
Catalog No. T4494Cas No. 34233-69-7
Select Batch
Purity:99.94%
Contact us for more batch information

Resource Download

CLOZAPINE N-OXIDE

Catalog No. T4494Cas No. 34233-69-7

Clozapine N-oxide is the major metabolite of Clozapine and is blood-brain barrier permeable. Clozapine N-oxide is an agonist of DREADDs and activates the DREADD receptors hM3Dq and hM4Di. Clozapine N-oxide is also a dopamine antagonist and selective muscarinic M4 receptor agonist.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
2 mg$30In Stock
5 mg$45In Stock
10 mg$76In Stock
25 mg$126In Stock
50 mg$187In Stock
100 mg$278In Stock
Bulk & Custom
Add to Cart

Product Introduction

Bioactivity
Description
Clozapine N-oxide is the major metabolite of Clozapine and is blood-brain barrier permeable. Clozapine N-oxide is an agonist of DREADDs and activates the DREADD receptors hM3Dq and hM4Di. Clozapine N-oxide is also a dopamine antagonist and selective muscarinic M4 receptor agonist.
In vitro
METHODS: hM4Di-transduced primary embryonic rat neuronal cultures were treated with Clozapine N-oxide (0.01-1000 nM), and activity on hM4Di receptors was detected by FLIPR assay.
RESULTS: The EC50 value for Clozapine N-oxide was 8.1 nM. [1]
METHODS: WT and hM3Dq-transfected mouse embryoma cells ATDC5 were treated with Clozapine N-oxide (750 nM) to detect intracellular calcium signaling.
RESULTS: Administration of Clozapine N-oxide resulted in immediate coordinated induction of single [Ca2+]i spines in hM3Dq-ATDC5 cells, and only spontaneous [Ca2+]i signaling was observed in Clozapine N-oxide-treated WT controls. [2]
In vivo
METHODS: To investigate potential effects on sleep, Clozapine N-oxide (1-10 mg/kg) was injected intraperitoneally into C57BL/6J mice.
RESULTS: Clozapine N-oxide altered sleep in mice. Sleep was analyzed using electroencephalography (EEG) and electromyography (EMG), revealing dose-dependent suppression of rapid eye movement (REM) sleep, changes in EEG spectral power during non-rapid eye movement (NREM) sleep, and alterations in sleep structure. [3]
METHODS: To investigate the effects on reward-seeking behavior, Clozapine N-oxide (0.1-10 mg/kg) was administered intraperitoneally to C57BL6/JJcl mice.
RESULTS: The off-target effects of commonly used doses of Clozapine N-oxide on motivated reward seeking were negligible. [4]
Chemical Properties
Molecular Weight342.82
FormulaC18H19ClN4O
Cas No.34233-69-7
Storage & Solubility Information
StoragePowder: -20°C for 3 years | Shipping with blue ice.
Solubility Information
Saline: 25 mg/mL (72.92 mM)
H2O: 1 mg/mL (2.92 mM), Sonication is recommended.
Ethanol: 10 mg/mL
DMSO: 60 mg/mL (175.02 mM), The compound is unstable in solution, please use soon.
Solution Preparation Table
H2O/Saline/DMSO
1mg5mg10mg50mg
1 mM2.9170 mL14.5849 mL29.1698 mL145.8491 mL
Saline/DMSO
1mg5mg10mg50mg
5 mM0.5834 mL2.9170 mL5.8340 mL29.1698 mL
10 mM0.2917 mL1.4585 mL2.9170 mL14.5849 mL
20 mM0.1458 mL0.7292 mL1.4585 mL7.2925 mL
50 mM0.0583 mL0.2917 mL0.5834 mL2.9170 mL
DMSO
1mg5mg10mg50mg
100 mM0.0292 mL0.1458 mL0.2917 mL1.4585 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CLOZAPINE N-OXIDE | purchase CLOZAPINE N-OXIDE | CLOZAPINE N-OXIDE cost | order CLOZAPINE N-OXIDE | CLOZAPINE N-OXIDE chemical structure | CLOZAPINE N-OXIDE in vivo | CLOZAPINE N-OXIDE in vitro | CLOZAPINE N-OXIDE formula | CLOZAPINE N-OXIDE molecular weight